Bin1 Attenuation Suppresses Experimental Colitis by Enforcing Intestinal Barrier Function
Digestive Diseases and Sciences, 04/24/2012Chang MY et al.
Bin1 is a genetic modifier of experimental colitis that controls the paracellular pathway of transcellular ion transport regulated by cellular tight junctions. The findings offer a preclinical validation of Bin1 as a novel therapeutic target for inflammatory bowel disease (IBD) treatment.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.